Lung giant cell carcinoma

MONDO:0006275

A morphologic variant of lung sarcomatoid carcinoma characterized by the presence of mononuclear and multinucleated pleomorphic neoplastic giant cells that lack cohesion.

Also known as: giant cell carcinoma, giant cell carcinoma of lung, giant cell carcinoma of the lung, lung giant cell carcinoma, GCLC

2807 clinical trials for this condition and its sub-types, 1 tagged with Lung giant cell carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Lung sarcomatoid carcinoma (7)

Including sub-types (2807) Tagged with Lung giant cell carcinoma (1)

Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors

Disease control Ongoing

This phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Lung giant cell carcinoma

Where it sits in the disease tree

Immunotherapy duo takes on rare tumors